| Original language | English |
|---|---|
| Pages (from-to) | 625-626 |
| Number of pages | 2 |
| Journal | JAMA Otolaryngology - Head and Neck Surgery |
| Volume | 151 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Jun 12 2025 |
Funding
Conflict of Interest Disclosures: Dr Saba reports personal fees from AstraZeneca, Eisai Medical, Exelixis/Merck, Merck, EMD Serono, Pfizer, Kura, Vaccinex, CUE, BionTech, GSK, TOSK, Seagen, Flamingo, Infinity, Inovio, Aveo, Medscape, Onclive, UpToDate, BMS, Cornerstone, Celldex, Surface Oncology, Urogen, Astex, Imugene, Faron Pharmaceutical, Coherus, Adagene, Fulgent Springer, Nanobiotix, and Taiho and funding from Exelixis and BMS outside the submitted work. No other disclosures were reported.
| Funders | Funder number |
|---|---|
| GlaxoSmithKline | |
| TOSK | |
| Exelixis Inc. | |
| Bamfield Marine Sciences Centre |
ASJC Scopus subject areas
- Surgery
- Otorhinolaryngology